Company: CSTL
Filing Date: 2025-03-28
Form Type: PRE 14A
Source: 0001447362-25-000050
Chunk: 78

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-03-28
Form: PRE 14A
Chunk 78
---
 above.

We did not engage in any repricing or other modifications or cancellations to any of our NEOs’ outstanding equity awards during the fiscal year ended December 31, 2024.

#### Castle Biosciences 2025 Proxy Statement71

#### Executive Compensation Tables

#### OPTION EXERCISES AND STOCK VESTED IN 2024
The following table sets forth information regarding exercises of stock options and vesting of stock awards, which includes RSUs and PSUs, and the value realized by our NEOs during the year ended December 31, 2024.

|                        |     | Option Awards |        |                                       |                            |         |     | Stock Awards |         |                                      |                           |           |
| Name                   |     |               |        | Number of shares acquired on exercise 
 (#)                                   | Value realized on exercise 
 ($)(1)                     |         |     |              |         | Number of shares acquired on vesting 
 (#)                                  | Value realized on vesting 
 ($)(2)                    |           |
| Derek J. Maetzold      |     |               | 10,686 |                                       |                            | 198,653 |     |              | 121,274 |                                      |                           | 3,448,649 |
| Frank Stokes           |     |               |      — |                                       |                            |       — |     |              |  32,531 |                                      |                           |   955,317 |
| Tobin W. Juvenal       |     |               | 11,308 |                                       |                            | 263,205 |     |              |  34,521 |                                      |                           | 1,013,493 |
| Kristen M. Oelschlager |     |               |      — |                                       |                            |       — |     |              |  34,521 |                                      |                           | 1,013,493 |

(1) Calculated based on the difference between the exercise price of each option exercised and the closing price of our common stock on the date of exercise multiplied by the number of shares underlying each option exercised and does not represent actual amounts received by the NEOs as a result of the option exercises.

(2) Calculated based on the closing price of our common stock on the vesting date multiplied by the number of shares underlying each award vested.

### POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE-IN-CONTROL
The following table describes the potential payments and benefits to which the NEOs would have